OX40-dependent antitumor immunity required both CD4+ and CD8+ T cells, and a significant proportion of treated mice remained tumor-free and resistant to rechallenge, supporting the notion that OX40 engagement promotes memory [71]. This evidence concerns the gene TNFRSF4 and neoplasm.